Evantic
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Ethos raises £17m Series A led by a16z to match job seekers to opportunities beyond CVs
Ethos is a platform that evaluates professional expertise using voice conversations and existing work such as code, research and content. It matches individuals to income opportunities including consulting, expert calls and full-time roles based on what they can do rather than what they claim.
Ineffable Intelligence lands over £800m in a seed round led by Sequoia and Lightspeed to develop superintelligence with reinforcement learning
Ineffable Intelligence is an AI research startup developing systems that learn from their own experience to discover new knowledge. It focuses on building a “superlearner” designed to advance reinforcement learning and scientific discovery.
ElevenLabs lands £370m Series D led by Sequoia Capital to double down on human-like AI text to speech model
ElevenLabs develops voice and audio AI models for text to speech, transcription and conversational systems. It provides production-ready tools for developers, creators and enterprises to generate and manage audio content.
Synthesia announces a £150m Series E led by Google Ventures to develop new conversational agents to support workplace learning
Synthesia creates AI-generated video tools for businesses, enabling organisations to produce training, learning and internal communications content using digital avatars and interactive, conversational video experiences.
- 4(12 months)
- evantic.ai
- Update Information
More venture news
- 10 Jun 2026
Capsa AICapsa AI lands £14m Series A led by TX Ventures and Pivot Investment Partners to build the AI operating system for private capital
Series AAI - 9 Jun 2026
NewOrbitNewOrbit raises £14m in a Series A led by Voyager Ventures to build the first commercial satellites for very low Earth orbit
Series ADeep Tech - 2 Jun 2026
IMU BiosciencesIMU Biosciences unlocks £40m Series A led by IQ Capital and Molten Ventures to decode the immune system with high-resolution blood analysis
Series ALife Sciences
